Synergistic therapy of human ovarian carcinoma implanted orthotopically in nude mice by optimal biological dose of pegylated interferon alpha combined with paclitaxel.

Tedjarati, Sean

Synergistic therapy of human ovarian carcinoma implanted orthotopically in nude mice by optimal biological dose of pegylated interferon alpha combined with paclitaxel. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Jul 2002 - 2413-22 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

1078-0432


Animals
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Apoptosis--drug effects
Blotting, Northern
Cell Division--drug effects
Drug Synergism
Endothelial Growth Factors--metabolism
Female
Fibroblast Growth Factor 2--metabolism
Fluorescent Antibody Technique
Humans
Immunoenzyme Techniques
In Situ Nick-End Labeling
Intercellular Signaling Peptides and Proteins--metabolism
Interferon alpha-2
Interferon-alpha--administration & dosage
Interleukin-8--metabolism
Lymphokines--metabolism
Matrix Metalloproteinase 9--metabolism
Mice
Mice, Nude
Neoplasm Transplantation
Ovarian Neoplasms--drug therapy
Paclitaxel--administration & dosage
Platelet Endothelial Cell Adhesion Molecule-1--metabolism
Polyethylene Glycols
Proliferating Cell Nuclear Antigen--metabolism
Recombinant Proteins
Tumor Cells, Cultured
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factors